Home
About
Overview
Sharing Data
ORCID
Help
History (78)
Ciliary Disassembly, a modifier of Autosomal Dominant Polycystic Kidney Disease
Naltrexone
Complement Activation in Patients With Probable Systemic Lupus Erythematosus and Ability to Predict Progression to American College of Rheumatology-Classified Systemic Lupus Erythematosus.
Bacterial Proteins
Erlotinib is not effective in patients with JAK2V617F-positive polycythemia vera.
See All 78 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Erlotinib is not effective in patients with JAK2V617F-positive polycythemia vera.
Erlotinib is not effective in patients with JAK2V617F-positive polycythemia vera. Ann Hematol. 2015 Apr; 94(4):717-9.
View in:
PubMed
subject areas
Adult
Aged
Amino Acid Substitution
Antineoplastic Agents
Drug-Related Side Effects and Adverse Reactions
Erlotinib Hydrochloride
Female
Humans
Janus Kinase 2
Male
Middle Aged
Phenylalanine
Polycythemia Vera
Quinazolines
Treatment Outcome
Valine
authors with profiles
Zhizhuang Joe Zhao
Mohamad Osama Khawandanah